ATE500276T1 - Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung - Google Patents
Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendungInfo
- Publication number
- ATE500276T1 ATE500276T1 AT05855920T AT05855920T ATE500276T1 AT E500276 T1 ATE500276 T1 AT E500276T1 AT 05855920 T AT05855920 T AT 05855920T AT 05855920 T AT05855920 T AT 05855920T AT E500276 T1 ATE500276 T1 AT E500276T1
- Authority
- AT
- Austria
- Prior art keywords
- humanized col
- antibodies
- disclosed
- col
- residies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64067204P | 2004-12-30 | 2004-12-30 | |
| PCT/US2005/047431 WO2006074071A1 (en) | 2004-12-30 | 2005-12-30 | Framework residue substituted humanized col-1 antibodies and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE500276T1 true ATE500276T1 (de) | 2011-03-15 |
Family
ID=36216923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05855920T ATE500276T1 (de) | 2004-12-30 | 2005-12-30 | Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7855276B2 (de) |
| EP (1) | EP1833850B9 (de) |
| AT (1) | ATE500276T1 (de) |
| AU (1) | AU2005322869B2 (de) |
| CA (1) | CA2593693A1 (de) |
| DE (1) | DE602005026706D1 (de) |
| WO (1) | WO2006074071A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2737597C (en) | 2008-10-16 | 2017-03-14 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| GB0914691D0 (en) | 2009-08-21 | 2009-09-30 | Lonza Biologics Plc | Immunoglobulin variants |
| US9175070B2 (en) | 2009-09-25 | 2015-11-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Neutralizing antibodies to HIV-1 and their use |
| CN103068851B (zh) | 2010-06-16 | 2015-03-11 | 高等教育联邦系统-匹兹堡大学 | 内质蛋白的抗体及其用途 |
| WO2012075327A1 (en) | 2010-12-02 | 2012-06-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods for treating a tumor using an antibody that specifically binds grp94 |
| CN104271597B (zh) | 2011-12-08 | 2018-05-25 | 美国政府(由卫生和人类服务部的部长所代表) | Hiv-1的中和抗体及其用途 |
| WO2014165271A2 (en) | 2013-03-13 | 2014-10-09 | Neotope Biosciences Limited | Tau immunotherapy |
| MX2018013384A (es) | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| US10906964B2 (en) | 2016-05-02 | 2021-02-02 | Prothena Biosciences Limited | Antibodies recognizing tau |
| EP3452507B1 (de) | 2016-05-02 | 2022-10-19 | Prothena Biosciences Limited | Tau-immuntherapie |
| SG11201910066QA (en) | 2017-05-02 | 2019-11-28 | Prothena Biosciences Ltd | Antibodies recognizing tau |
| TWI859197B (zh) | 2019-03-03 | 2024-10-21 | 愛爾蘭商普羅帝納生物科學公司 | 識別tau之抗體 |
| CN113393899A (zh) * | 2021-05-26 | 2021-09-14 | 江苏普瑞康生物医药科技有限公司 | 基于动态规划的抗体人源化的方法与装置 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5851526A (en) * | 1985-04-19 | 1998-12-22 | Ludwig Institute For Cancer Research | Methods of treating colon cancer utilizing tumor-specific antibodies |
| GB8800077D0 (en) * | 1988-01-05 | 1988-02-10 | Ciba Geigy Ag | Novel chimeric antibodies |
| US5472693A (en) * | 1993-02-16 | 1995-12-05 | The Dow Chemical Company | Family of anti-carcinoembryonic antigen chimeric antibodies |
| US6417337B1 (en) * | 1996-10-31 | 2002-07-09 | The Dow Chemical Company | High affinity humanized anti-CEA monoclonal antibodies |
| WO2000026394A1 (en) | 1998-10-31 | 2000-05-11 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| US7321026B2 (en) | 2001-06-27 | 2008-01-22 | Skytech Technology Limited | Framework-patched immunoglobulins |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| AU2003270369A1 (en) * | 2002-09-05 | 2004-03-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen |
| US7355008B2 (en) * | 2003-01-09 | 2008-04-08 | Macrogenics, Inc. | Identification and engineering of antibodies with variant Fc regions and methods of using same |
-
2005
- 2005-12-30 CA CA002593693A patent/CA2593693A1/en not_active Abandoned
- 2005-12-30 AT AT05855920T patent/ATE500276T1/de not_active IP Right Cessation
- 2005-12-30 WO PCT/US2005/047431 patent/WO2006074071A1/en not_active Ceased
- 2005-12-30 AU AU2005322869A patent/AU2005322869B2/en not_active Ceased
- 2005-12-30 US US11/813,092 patent/US7855276B2/en not_active Expired - Fee Related
- 2005-12-30 DE DE602005026706T patent/DE602005026706D1/de not_active Expired - Lifetime
- 2005-12-30 EP EP05855920A patent/EP1833850B9/de not_active Expired - Lifetime
-
2010
- 2010-11-15 US US12/946,381 patent/US8828717B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20080274055A1 (en) | 2008-11-06 |
| WO2006074071A1 (en) | 2006-07-13 |
| US8828717B2 (en) | 2014-09-09 |
| US7855276B2 (en) | 2010-12-21 |
| DE602005026706D1 (de) | 2011-04-14 |
| WO2006074071A8 (en) | 2006-09-14 |
| AU2005322869A1 (en) | 2006-07-13 |
| EP1833850B9 (de) | 2011-05-18 |
| AU2005322869B2 (en) | 2011-05-12 |
| EP1833850B1 (de) | 2011-03-02 |
| US20110053264A1 (en) | 2011-03-03 |
| CA2593693A1 (en) | 2006-07-13 |
| EP1833850A1 (de) | 2007-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60333732D1 (de) | Internalisierung von anti cd74 monoklonalen antikörpern und deren verwendungen | |
| JP2017508475A5 (de) | ||
| ATE492563T1 (de) | Vollständige humane monoklonale antikörper gegen il-13 | |
| NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
| TR200807263T1 (tr) | IgG'nin FcRn'ye bağlanmasını bloke eden peptidler | |
| RU2421464C2 (ru) | Человеческие антитела к il-13 и их терапевтическое применение | |
| DE602005026706D1 (de) | Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung | |
| ZA200702879B (en) | Single domain antibodies against TNFR1 and methods of use therefor | |
| DE60239454D1 (de) | Rekombinanter, tumorspezifischer antikörper und dessen verwendung | |
| EA201590631A1 (ru) | Антигенсвязывающие белки, способные связывать тимусный стромальный лимфопоэтин | |
| NO20090462L (no) | Anti-NKG2A-antistoffer og anvendelser derav | |
| NZ592054A (en) | Dengue virus neutralizing antibodies and uses thereof | |
| WO2007092939A8 (en) | Antigenic gm-csf peptides and antibodies to gm-csf | |
| MX343879B (es) | Metodo de humanizacion de anticuerpo de conejo novedoso y anticuerpos de conejo humanizados. | |
| SG151284A1 (en) | Antibodies against ccr5 and uses thereof | |
| WO2004083249A3 (en) | Antibodies against human il-21 receptor and uses therefor | |
| ATE373719T1 (de) | Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung | |
| WO2006099141A3 (en) | Anti-mesothelin antibodies | |
| DE60329823D1 (de) | Antikörper mit t-zell-rezeptor-artiger spezifität, aber höherer affinität und seine verwendung zum nachweis und zur behandlung von krebs, virusinfektionen und autoimmunkrankheiten | |
| GEP20115226B (en) | P-cadherin antibodies | |
| ATE452147T1 (de) | Antikörper mit korrigierten cdr | |
| UA105760C2 (uk) | Антитіло проти bst2 | |
| IN2012DN05101A (de) | ||
| WO2004035742A3 (en) | Sets of digital antibodies directed against short epitopes, and methods using same | |
| EA200700876A1 (ru) | Агенты, специфически связывающие ангиопоэтин-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |